Is Omeprazole / Esomeprazole sold as a single enantiomer or racemic mixture?

Racemic Prilosec is OTC; S-omeprazole (Nexium) is prescription

Omeprazole / Esomeprazole Enantiomers - Chirality in Pharmacology

What happens with Omeprazole / Esomeprazole enantiomers?

Omeprazole / Esomeprazole is a Proton Pump Inhibitor. The S-enantiomer is More effective acid suppression, while the R-enantiomer is Less bioavailable, faster metabolism. Esomeprazole (pure S-form) was one of the most profitable "chiral switches" in pharmaceutical history. AstraZeneca patented it separately from racemic omeprazole (Prilosec) to extend market exclusivity.

Drug Name	Omeprazole / Esomeprazole
Drug Class	Proton Pump Inhibitor
R-Enantiomer Activity	Less bioavailable, faster metabolism
S-Enantiomer Activity	More effective acid suppression
FDA Status	Racemic Prilosec is OTC; S-omeprazole (Nexium) is prescription
Year of Discovery	1979
Clinical Significance	Esomeprazole (pure S-form) was one of the most profitable "chiral switches" in pharmaceutical history. AstraZeneca patented it separately from racemic omeprazole (Prilosec) to extend market exclusivity.

Introduction

Omeprazole is a proton pump inhibitor that reduces stomach acid production. The racemic form (Prilosec) contains both S and R enantiomers, but their pharmacological profiles differ significantly.

Structure Comparison

Both enantiomers share the same atoms and bonds - a sulfoxide group connecting a methoxy-pyridine ring to a benzimidazole ring. The difference is the spatial arrangement around the sulfur atom.

Chiral Center

The chiral center is the sulfur atom in the sulfoxide group. Sulfur has four different substituents: the oxygen, the methylene bridge, a lone pair, and the benzimidazole ring.

Pharmacological Differences

S-omeprazole (esomeprazole) has higher bioavailability because it is metabolized more slowly by liver enzymes (CYP2C19). The R-form is cleared faster, leading to lower plasma concentrations.

Clinical Impact

AstraZeneca performed a "chiral switch" - isolating the S-enantiomer and marketing it as Nexium. This became a multibillion-dollar drug and extended patent protection beyond the original Prilosec.

Key Takeaway

The omeprazole/esomeprazole case shows how stereochemistry directly affects drug metabolism and bioavailability, and how the pharmaceutical industry leverages single-enantiomer formulations.

Visualize R and S enantiomers side by side with activity indicators and pharmacological profiles.

Compare Omeprazole / Esomeprazole Enantiomers in 3D